Linaclotide capsules are a medication used to treat adults with constipation-predominant irritable bowel syndrome.
This document is the package insert for Linzess (Linaclotide) capsules, a prescription medication indicated for the treatment of adult constipation-predominant irritable bowel syndrome (IBS-C). The active ingredient is Linaclotide, supplied in 290μg capsules. The recommended dosage for adults is one capsule daily, taken at least 30 minutes before the first meal of the day.
The insert details the pharmacological properties, clinical trial results, and safety profile of the drug. Common adverse reactions include diarrhea, abdominal pain, and bloating. It contains specific warnings regarding the use of the drug in pediatric patients (under 6 years old) and elderly patients, as well as information on drug interactions and contraindications. This manual is written in Chinese.
| Active Ingredient | Linaclotide |
|---|---|
| Dosage Form | Capsules |
| Strength | 290μg |
| Indication | Adult constipation-predominant irritable bowel syndrome (IBS-C) |
| Recommended Dosage | One capsule daily, at least 30 minutes before the first meal |
No. Linzess is contraindicated in children under 6 years of age, and its use is not recommended for children aged 6 to 18 years due to safety and efficacy concerns.
Adults should take one capsule daily at least 30 minutes before the first meal of the day.